Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2020-11-13
DOI
10.1080/17512433.2021.1851192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
- (2020) Dolores Shoback et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cumulative network meta-analyses, practice guidelines, and actual prescriptions for postmenopausal osteoporosis: a meta-epidemiological study
- (2020) Yuki Kataoka et al. Archives of Osteoporosis
- Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis
- (2019) Patricia Barrionuevo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparative efficacy and safety of pharmacological interventions for osteoporosis in postmenopausal women
- (2019) Xiang Tan et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Effect of medications on prevention of secondary osteoporotic vertebral compression fracture, non-vertebral fracture, and discontinuation due to adverse events: a meta-analysis of randomized controlled trials
- (2019) Yuan-Zhe Jin et al. BMC MUSCULOSKELETAL DISORDERS
- Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab
- (2019) D.L. Kendler et al. OSTEOPOROSIS INTERNATIONAL
- Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial
- (2019) Joy N Tsai et al. Lancet Diabetes & Endocrinology
- Denosumab: A Review in Postmenopausal Osteoporosis
- (2018) Emma D. Deeks DRUGS & AGING
- THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis
- (2018) Athanasios D Anastasilakis et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
- (2018) Michael R McClung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials
- (2018) Shenghan Lou et al. BMJ Open
- The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis
- (2018) Anne Sophie Koldkjær Sølling et al. Therapeutic Advances in Musculoskeletal Disease
- One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study
- (2018) E Michael Lewiecki et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women
- (2017) Joan Lappe et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
- (2017) Bente L Langdahl et al. LANCET
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis
- (2017) T. Saito et al. OSTEOPOROSIS INTERNATIONAL
- Tratamento da osteoporose pós‐menopáusica: um algoritmo baseado na literatura para uso no sistema público de saúde
- (2017) Ellen Luz Pereira Caires et al. Revista Brasileira De Reumatologia
- Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study
- (2017) Bo-cheng Liang et al. Orthopaedic Surgery
- Network Meta-Analysis of Pharmacological Agents for Osteoporosis Treatment and Fracture Prevention
- (2016) Xu-cheng Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Teriparatide for osteoporosis: importance of the full course
- (2016) R. Lindsay et al. OSTEOPOROSIS INTERNATIONAL
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
- (2015) Brian Hutton et al. ANNALS OF INTERNAL MEDICINE
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- A painful, never ending story: older women’s experiences of living with an osteoporotic vertebral compression fracture
- (2015) H. K. Svensson et al. OSTEOPOROSIS INTERNATIONAL
- The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study
- (2015) S. Papapoulos et al. OSTEOPOROSIS INTERNATIONAL
- Denosumab versus zoledronic acid in patients previously treated with zoledronic acid
- (2015) A. D. Anastasilakis et al. OSTEOPOROSIS INTERNATIONAL
- Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation
- (2015) C. M. Weaver et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy and Safety of Single-Dose Zoledronic Acid for Osteoporosis in Frail Elderly Women
- (2015) Susan L. Greenspan et al. JAMA Internal Medicine
- Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate
- (2015) A. Catalano et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Effects of intravenous zoledronate and ibandronate on carotid intima-media thickness, lipids and FGF-23 in postmenopausal osteoporotic women
- (2014) S. Gonnelli et al. BONE
- Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women
- (2014) Alexandra G. Ellis et al. CURRENT MEDICAL RESEARCH AND OPINION
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
- (2014) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cortical bone loss at the tibia in postmenopausal women with osteoporosis is associated with incident non-vertebral fractures: Results of a randomized controlled ancillary study of HORIZON
- (2014) A.W. Popp et al. MATURITAS
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study
- (2014) M. A. Paggiosi et al. OSTEOPOROSIS INTERNATIONAL
- Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review
- (2013) Erik F. Eriksen et al. BONE
- Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
- (2013) C. Roux et al. BONE
- Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis
- (2013) Núria Guañabens et al. HEPATOLOGY
- Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women
- (2013) Hua Bai et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy
- (2013) Chris Recknor et al. OBSTETRICS AND GYNECOLOGY
- Pathophysiology of Osteoporosis
- (2012) Laura A.G. Armas et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis
- (2012) Mohammad Hassan Murad et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women
- (2011) Robert B Hopkins et al. BMC MUSCULOSKELETAL DISORDERS
- Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis
- (2011) Z. Sanad et al. CLIMACTERIC
- Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
- (2011) Socrates Papapoulos et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Low-Dose Zoledronate in Osteopenic Postmenopausal Women: A Randomized Controlled Trial
- (2011) Andrew Grey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
- (2011) J-Y. Reginster et al. OSTEOPOROSIS INTERNATIONAL
- New Treatment Modalities in Osteoporosis
- (2010) Ernesto Canalis Endocrine Practice
- Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis
- (2010) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Long-Term Use of Bisphosphonates in Osteoporosis
- (2010) Nelson B. Watts et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009
- (2010) S. Lee et al. OSTEOPOROSIS INTERNATIONAL
- Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years
- (2009) J.Y. Reginster et al. BONE
- Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women
- (2009) Yoon-Sok Chung et al. CALCIFIED TISSUE INTERNATIONAL
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass
- (2009) Michael McClung et al. OBSTETRICS AND GYNECOLOGY
- Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
- (2009) P. J. Meunier et al. OSTEOPOROSIS INTERNATIONAL
- Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial
- (2008) Jean-Yves Reginster et al. ARTHRITIS AND RHEUMATISM
- Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL*
- (2008) Paul J Kostenuik et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Antiresorptive Effects of a Single Dose of Zoledronate Persist for Two Years: A Randomized, Placebo-Controlled Trial in Osteopenic Postmenopausal Women
- (2008) Andrew Grey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vitamin D status and response to treatment in post-menopausal osteoporosis
- (2008) S. Adami et al. OSTEOPOROSIS INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search